Ambarella Inc (AMBA) stock
AMBANasdaqSemiconductors & Related DevicesFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 4, 2026Score 8/301% above fair value
$61.06−1.43 (-2.29%)
Close on Nov 12, 2026Market cap $2.70BP/E –Yield –
Ambarella EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Ambarella's EPS for the twelve months ending Jul 31, 2026 was -$1.29. For fiscal 2026 it was -$1.78. The highest annual figure on record is $2.27 in fiscal 2016.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | -$1.78 | – |
| FY2025 | Jan 31, 2025 | -$2.84 | – |
| FY2024 | Jan 31, 2024 | -$4.25 | – |
| FY2023 | Jan 31, 2023 | -$1.70 | – |
| FY2022 | Jan 31, 2022 | -$0.72 | – |
| FY2021 | Jan 31, 2021 | -$1.72 | – |
| FY2020 | Jan 31, 2020 | -$1.35 | – |
| FY2019 | Jan 31, 2019 | -$0.93 | -269.1% |
| FY2018 | Jan 31, 2018 | $0.55 | -67.3% |
| FY2017 | Jan 31, 2017 | $1.68 | -26.0% |
| FY2016 | Jan 31, 2016 | $2.27 | +44.6% |
| FY2015 | Jan 31, 2015 | $1.57 | +84.7% |
| FY2014 | Jan 31, 2014 | $0.85 | +41.7% |
| FY2013 | Jan 31, 2013 | $0.60 | +100.0% |
| FY2012 | Jan 31, 2012 | $0.30 | -40.0% |
| FY2011 | Jan 31, 2011 | $0.50 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | -$0.15 | – |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | -$0.41 | – |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | -$0.38 | – |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | -$0.35 | – |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | -$0.47 | – |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | -$0.58 | – |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | -$0.48 | – |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | -$0.58 | – |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | -$0.85 | – |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | -$0.93 | – |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | -$1.50 | – |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | -$1.04 | – |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | -$0.79 | – |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | -$0.91 | – |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | -$0.29 | – |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | -$0.51 | -2650.0% |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | -$0.62 | – |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | -$0.29 | – |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | -$0.25 | – |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | $0.02 | – |
| Q2 FY2022CQ2 2021 | Jul 31, 2021 | -$0.20 | – |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | -$0.30 | – |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | -$0.35 | – |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | -$0.49 | – |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | -$0.43 | – |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | -$0.45 | – |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | -$0.39 | – |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | -$0.13 | – |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | -$0.31 | – |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | -$0.53 | – |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | -$0.14 | -450.0% |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | -$0.28 | -182.4% |
| Q2 FY2019CQ2 2018 | Jul 31, 2018 | -$0.21 | -310.0% |
| Q1 FY2019CQ1 2018 | Apr 30, 2018 | -$0.30 | -528.6% |
| Q4 FY2018CQ4 2017 | Jan 31, 2018 | $0.04 | -92.5% |
| Q3 FY2018CQ3 2017 | Oct 31, 2017 | $0.34 | -59.5% |
| Q2 FY2018CQ2 2017 | Jul 31, 2017 | $0.10 | – |
| Q1 FY2018CQ1 2017 | Apr 30, 2017 | $0.07 | – |
| Q4 FY2017CQ4 2016 | Jan 31, 2017 | $0.53 | – |
| Q3 FY2017CQ3 2016 | Oct 31, 2016 | $0.84 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?